IPEX as a Result of Mutations in FOXP3

por van der Vliet, Hans J. J., Nieuwenhuis, Edward E.
Publicado 2007

CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond

por King, Lisa A., Lameris, Roeland, de Gruijl, Tanja D., van der Vliet, Hans J.
Publicado 2018

Corrigendum: CD1d-Invariant Natural Killer T Cell-Based Cancer Immunotherapy: α-Galactosylceramide and Beyond

por King, Lisa A., Lameris, Roeland, de Gruijl, Tanja D., van der Vliet, Hans J.
Publicado 2018

Positive & Negative Roles of Innate Effector Cells in Controlling Cancer Progression

por Stolk, Dorian, van der Vliet, Hans J., de Gruijl, Tanja D., van Kooyk, Yvette, Exley, Mark A.
Publicado 2018

The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future Developments

por Veluchamy, John P., Kok, Nina, van der Vliet, Hans J., Verheul, Henk M. W., de Gruijl, Tanja D., Spanholtz, Jan
Publicado 2017

Irinotecan-Induced Dysarthria

por Dressel, Albertine J., van der Mijn, Johannes C., Aalders, IJke J., Rinkel, Rico N.P.M., van der Vliet, Hans J.
Publicado 2012

Specific tumor targeting and activation of Vγ9Vδ2 T cells by bi-specific nanobodies

por Stam, Anita, de Bruin, Renée, Roovers, Rob, van Bergen en Henegouwen, Paul, Verheul, Henk, de Gruijl, Tanja D, van der Vliet, Hans
Publicado 2014

Immunological effects of everolimus in patients with metastatic renal cell cancer

por Huijts, Charlotte M, Santegoets, Saskia J, de Jong, Tamarah D, Verheul, Henk M, de Gruijl, Tanja D, van der Vliet, Hans J
Publicado 2017

Tumor Mutational Burden and Efficacy of Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis

por Kim, Jong Yeob, Kronbichler, Andreas, Eisenhut, Michael, Hong, Sung Hwi, van der Vliet, Hans J., Kang, Jeonghyun, Shin, Jae Il, Gamerith, Gabriele
Publicado 2019

Efficacy of Cancer Immunotherapy: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials

por Kim, Jong Yeob, Lee, Keum Hwa, Eisenhut, Michael, van der Vliet, Hans J., Kronbichler, Andreas, Jeong, Gwang Hun, Shin, Jae Il, Gamerith, Gabriele
Publicado 2019

Statin and Cancer Mortality and Survival: An Umbrella Systematic Review and Meta-Analysis

por Jeong, Gwang Hun, Lee, Keum Hwa, Kim, Jong Yeob, Eisenhut, Michael, Kronbichler, Andreas, van der Vliet, Hans J., Shin, Jae Il, Gamerith, Gabriele
Publicado 2020

A Phase I Open‐Label Clinical Trial Evaluating the Therapeutic Vaccine hVEGF26–104/RFASE in Patients with Advanced Solid Malignancies

por Goedegebuure, Ruben S.A., Wentink, Madelon Q., van der Vliet, Hans J., Timmerman, Peter, Griffioen, Arjan W., de Gruijl, Tanja D., Verheul, Henk M.W.
Publicado 2020

Standardized and flexible eight colour flow cytometry panels harmonized between different laboratories to study human NK cell phenotype and function

por Veluchamy, John P., Delso-Vallejo, María, Kok, Nina, Bohme, Fenna, Seggewiss-Bernhardt, Ruth, van der Vliet, Hans J., de Gruijl, Tanja D., Huppert, Volker, Spanholtz, Jan
Publicado 2017

Effect of Statin on Cancer Incidence: An Umbrella Systematic Review and Meta-Analysis

por Jeong, Gwang Hun, Lee, Keum Hwa, Kim, Jong Yeob, Eisenhut, Michael, Kronbichler, Andreas, van der Vliet, Hans J., Hong, Sung Hwi, Shin, Jae Il, Gamerith, Gabriele
Publicado 2019

Enhanced CD1d phosphatidylserine presentation using a single-domain antibody promotes immunomodulatory CD1d-TIM-3 interactions

por Lameris, Roeland, Shahine, Adam, Veth, Myrthe, Westerman, Bart, Godfrey, Dale I, Lutje Hulsik, David, Brouwer, Patricia, Rossjohn, Jamie, de Gruijl, Tanja D, van der Vliet, Hans J
Publicado 2023

Combination of NK Cells and Cetuximab to Enhance Anti-Tumor Responses in RAS Mutant Metastatic Colorectal Cancer

por Veluchamy, John Pradeep, Spanholtz, Jan, Tordoir, Marleen, Thijssen, Victor L., Heideman, Daniëlle A. M., Verheul, Henk M. W., de Gruijl, Tanja D., van der Vliet, Hans J.
Publicado 2016

Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-Future

por Saura-Esteller, José, de Jong, Milon, King, Lisa A., Ensing, Erik, Winograd, Benjamin, de Gruijl, Tanja D., Parren, Paul W. H. I., van der Vliet, Hans J.
Publicado 2022

Phase I-II study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell cancer

por Huijts, Charlotte M, Santegoets, Saskia J, van den Eertwegh, Alfons J, Pijpers, Laura S, Haanen, John B, de Gruijl, Tanja D, Verheul, Henk M, van der Vliet, Hans J
Publicado 2011

Preclinical Evaluation of Invariant Natural Killer T Cells Modified with CD38 or BCMA Chimeric Antigen Receptors for Multiple Myeloma

por Poels, Renée, Drent, Esther, Lameris, Roeland, Katsarou, Afroditi, Themeli, Maria, van der Vliet, Hans J., de Gruijl, Tanja D., van de Donk, Niels W. C. J., Mutis, Tuna
Publicado 2021

Effects of physical exercise on natural killer cell activity during (neo)adjuvant chemotherapy: A randomized pilot study

por Toffoli, Elisa C., Sweegers, Maike G., Bontkes, Hetty J., Altenburg, Teatske M., Verheul, Henk M.W., van der Vliet, Hans J., de Gruijl, Tanja D., Buffart, Laurien M.
Publicado 2021